Influence of proteolytic enzymes and calcium-binding agents on nuclear and cell surface topography.
Transmission electron microscopy was used to study the effects of proteolytic enzymes (collagenase, trypsin, clostripain), the calcium chelator ethyleneglycol-bis-(beta-aminoethyl ether) N,N,N',N'-tetraacetic acid (EGTA), and the calcium ionophore A 23187 on substrate adhesion and fine structure of chondrocytes and fibroblasts. Monolayer-cultured cells responded to treatment with the proteolytic enzymes followed by EGTA or A 23187 by rounding and detaching from the substrate. This was accompanied by the formation of a microvillous surface, deep nuclear folds, and numerous cytoplasmic vacuoles. Labeling experiments with colloidal thorium dioxide indicated that the vacuoles were formed by endocytosis and fusion of endocytic vesicles with preexisting lysosomes. To a variable extent, similar changes were produced by trypsin or EGTA alone. The cells regained their normal fine structure after withdrawal of the reagents and when seeded onto a substrate. In suspension culture, recovery was incomplete; the cells retained a rounded shape and an increased number of cytoplasmic vacuoles. The results suggest that changes in plasma membrane composition and its permeability to calcium represent the primary signal for cell rounding and detachment. The cellular mechanisms responsible for the associated folding of the nuclear envelope and the cell surface remain unidentified. Nevertheless, this is believed to represent a means of handling of excess membrane during sudden transition from a flattened to a rounded shape. Membrane stored in folds and vacuoles is reutilized when the cells reattach and spread out on a substrate.
D000818:Animals; D000001:Calcimycin / Q000494:pharmacology*; D002356:Cartilage / Q000648:ultrastructure; D002462:Cell Membrane / Q000187:drug effects / Q000648:ultrastructure*; D002467:Cell Nucleus / Q000187:drug effects / Q000648:ultrastructure*; D003546:Cysteine Endopeptidases; D004533:Egtazic Acid / Q000494:pharmacology*; D004622:Embryo, Mammalian; D010450:Endopeptidases / Q000494:pharmacology*; D005026:Ethylene Glycols / Q000494:pharmacology*; D005347:Fibroblasts / Q000648:ultrastructure; D006367:HeLa Cells / Q000648:ultrastructure; D006801:Humans; D051379:Mice; D003012:Microbial Collagenase / Q000494:pharmacology*; D008854:Microscopy, Electron; D012867:Skin / Q000648:ultrastructure; D014357:Trypsin / Q000494:pharmacology*
D005026:Ethylene Glycols; D000001:Calcimycin; D004533:Egtazic Acid; D010450:Endopeptidases; D014357:Trypsin; D003546:Cysteine Endopeptidases; C019913:clostripain; D003012:Microbial Collagenase